MedPath

The analysis of mucosal immune responses induced by intranasal administration of an inactivated influenza virus vaccine in human (IV).

Not Applicable
Conditions
Influenza
Registration Number
JPRN-UMIN000009106
Lead Sponsor
ational Institute of Infectious Diseases
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1. Volunteers with a fever at the time of planned vaccination. 2. Volunteers with serious acute diseases. 3. Volunteers considered inappropriate to be inoculated with the vaccine.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eutralization, HI, and HA-specific antibody titers before and after intranasal vaccination. The proportion of memory B cells or plasma cells in peripheral blood mononuclear cells, and the cytokine profile.
Secondary Outcome Measures
NameTimeMethod
The analysis of the antibody repertoire induced by the intranasal vaccination. Survey on side reaction after vaccination.
© Copyright 2025. All Rights Reserved by MedPath